Peritoneal Dialysis International Journal

Peritoneal Dialysis International (PDI) - Official Journal of @ISPD1. #PeritonealDialysis
EIC: @PD_Perls
SoMe Ed: @dr_nikhilshah
VA: @edgarvlermamd @jmteakell

[ISPD 2026 Cape Town Congress @ISPDCongress]

#ISPD26 Cape Town: closing of extension of early-bird registration deadline: Sunday May 17th!

Register now and enjoy the best rates - https://t.co/GfzePx33cf

[ISPD 2026 Cape Town Congress @ISPDCongress]

After multiple requests, the Early Bird registration period has been extended two weeks!

Participants awaiting confirmation of funding or finalising arrangements may still benefit from up to 30% discounted fees if they register before 17th May

REGISTER: https://t.co/V8NhkOUHW1

[Peritoneal Dialysis International Journal @PDI_Journal]

BRI may serve as a convenient anthropometric marker for central adiposity in prevalent PD patients. The inconsistent prognostic value between incident and prevalent cohorts warrants cautious interpretation.

[Peritoneal Dialysis International Journal @PDI_Journal]

#PDI #PeritonealDialysis #Nephrology #ISPD #Obesity

https://t.co/1cjpNhfSFy
Does the Body Roundness Index (BRI), a marker of central adiposity, predict mortality and clinical outcomes in patients undergoing peritoneal dialysis?

[Peritoneal Dialysis International Journal @PDI_Journal]

Higher BRI also correlated with increased hospitalization frequency (p=0.001) and longer hospital stays (p=0.002) in prevalent patients. In a validation cohort of 162 incident PD patients, the association with survival lost significance after multivariable adjustment.

[Peritoneal Dialysis International Journal @PDI_Journal]

Maintaining robust peritoneal dialysis programs requires ongoing infrastructure support, adequate reimbursement, and clinical training, even as modality choice broadens. Read the full policy analysis in PDI.

[Peritoneal Dialysis International Journal @PDI_Journal]

Thailand's dialysis policy evolution and the "success paradox" of modality choice reforms. 🇹🇭
https://t.co/XfYe3hM9OW

[Peritoneal Dialysis International Journal @PDI_Journal]

Recent policy reforms have shifted toward shared decision-making, removing financial disincentives for hemodialysis. This transition presents a "success paradox," where initial policy triumphs create new structural and economic challenges for modality distribution.

[Int. Soc. for Peritoneal Dialysis @ISPD1]

Yesterday was #EarthDay2026! We invite you to revisit our post on the topic, written by Dr @WinstonFung1 (Hong Kong), highlighting the role that PD can play in making dialysis more sustainable and presenting upcoming "green" articles on the @PDI Journal.
https://t.co/YRbsl9IUI0

[Peritoneal Dialysis International Journal @PDI_Journal]

Just starting for Africa Chapter Webinar! Join here https://t.co/tUIHY11sjL

[Int. Soc. for Peritoneal Dialysis @ISPD1]

STARTING SOON (in 15')!
The first ISPD Africa Chapter webinar: Advancing PD in Africa.

The webinar does not require registration. When it is about to start, please click on the link: https://t.co/EeHu7Gojfw

WHEN: today Thursday, at 16:00 GMT / 18:00 CAT / 19:00 EAT).

[Peritoneal Dialysis International Journal @PDI_Journal]

Starting now!

[Int. Soc. for Peritoneal Dialysis @ISPD1]

REMINDER: 1st ISPD Middle East Chapter Webinar today 12h00 GMT / 15h00 AST / 16:00 GST

THEME: Advancing #PeritonealDialysis in the Middle East: Clinical, Cultural and System Perspectives

REGISTER LINK: https://t.co/JdiMB6DiV9

[Peritoneal Dialysis International Journal @PDI_Journal]

Clinical Pearl: A review of 67 M. abscessus PD infections showed 6 historical cases treated with clofazimine achieved cure. This is the FIRST reported success for a macrolide-resistant strain! Clofazimine is a viable oral combo-therapy option. 5/5

[Peritoneal Dialysis International Journal @PDI_Journal]

A new Case Report in #PDI explores how a clofazimine-inclusive combination therapy successfully treated a stubborn, macrolide-resistant Mycobacterium abscessus PD infection! 🧵 1/5
https://t.co/nh1aY2aWIT
#peritonealdialysis #ISPD

[Peritoneal Dialysis International Journal @PDI_Journal]

The Results: After 4 weeks of imipenem-cilastatin, amikacin, azithromycin, and clofazimine, followed by 4 months of continuation therapy, the patient achieved sustained clinical cure! He remains recurrence-free at 14 months follow-up. 4/5

[Peritoneal Dialysis International Journal @PDI_Journal]

6/6 📝 Takeaway: Don't wait for the cocoon. In long-term PD patients, monitor ascites production rates during pauses. It could be the key to early EPS intervention.
Read the full paper by Hsieh et al. in @PDI_Journal

[Peritoneal Dialysis International Journal @PDI_Journal]

1/6 🧵 Diagnosing Encapsulating Peritoneal Sclerosis (EPS) early is notoriously difficult. A new case in #PDI suggests a subtle clinical sign may precede definitive radiological evidence. #PeritonealDialysis #PD #Nephrology
🔗 https://t.co/YzchjlMYk5

[Peritoneal Dialysis International Journal @PDI_Journal]

5/6 ✅ Outcome: Ascites volume decreased over time, and the patient's weight and appetite recovered. This highlights that "rapid accumulation" can be a vital early warning sign in high-risk patients.